pharma · Age-related Macular Degeneration · Neovascular Age-related Macular Degeneration · OTLK
Outlook Therapeutics NL
Outlook Therapeutics NL B. V.
Outlook Therapeutics NL clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Cranbury, USA HQ
2011 Founded
59 Employees
Public company Type
OTLK · NYSE Ticker
Company details
- Status
- Public
- HQ
- Cranbury, USA
- Founded
- 2011
- Employees
- 59
- Programs
- 2
- Drugs
- 3
- Patents
- 2
Outlook Therapeutics NL projects
2 ClinicalTrials.gov programs sponsored by Outlook Therapeutics NL.
Outlook Therapeutics NL has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Outlook Therapeutics NL have?
2 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.